nodes	percent_of_prediction	percent_of_DWPC	metapath
Vigabatrin—GABBR1—nipple—breast cancer	0.0163	0.0911	CbGeAlD
Vigabatrin—ABAT—mammary gland—breast cancer	0.0154	0.086	CbGeAlD
Vigabatrin—GABBR1—endometrium—breast cancer	0.00985	0.055	CbGeAlD
Vigabatrin—GABBR1—uterus—breast cancer	0.00907	0.0507	CbGeAlD
Vigabatrin—GABBR1—pituitary gland—breast cancer	0.00891	0.0498	CbGeAlD
Vigabatrin—GABBR1—adipose tissue—breast cancer	0.00887	0.0496	CbGeAlD
Vigabatrin—GABBR1—adrenal gland—breast cancer	0.00796	0.0445	CbGeAlD
Vigabatrin—GABBR1—bone marrow—breast cancer	0.0077	0.043	CbGeAlD
Vigabatrin—GABBR1—female gonad—breast cancer	0.00742	0.0414	CbGeAlD
Vigabatrin—SLC36A1—uterus—breast cancer	0.00713	0.0398	CbGeAlD
Vigabatrin—SLC36A1—adipose tissue—breast cancer	0.00697	0.0389	CbGeAlD
Vigabatrin—ABAT—pituitary gland—breast cancer	0.00695	0.0388	CbGeAlD
Vigabatrin—ABAT—adipose tissue—breast cancer	0.00693	0.0387	CbGeAlD
Vigabatrin—L-Glutamine—TGM2—breast cancer	0.00649	1	CrCbGaD
Vigabatrin—SLC36A1—female reproductive system—breast cancer	0.00641	0.0358	CbGeAlD
Vigabatrin—SLC36A1—adrenal gland—breast cancer	0.00625	0.0349	CbGeAlD
Vigabatrin—ABAT—adrenal gland—breast cancer	0.00621	0.0347	CbGeAlD
Vigabatrin—SLC36A1—bone marrow—breast cancer	0.00605	0.0338	CbGeAlD
Vigabatrin—SLC36A1—female gonad—breast cancer	0.00583	0.0326	CbGeAlD
Vigabatrin—ABAT—female gonad—breast cancer	0.00579	0.0324	CbGeAlD
Vigabatrin—SLC36A1—endocrine gland—breast cancer	0.00542	0.0303	CbGeAlD
Vigabatrin—ABAT—endocrine gland—breast cancer	0.00539	0.0301	CbGeAlD
Vigabatrin—GABBR1—lymph node—breast cancer	0.00477	0.0266	CbGeAlD
Vigabatrin—SLC36A1—lymph node—breast cancer	0.00375	0.0209	CbGeAlD
Vigabatrin—ABAT—lymph node—breast cancer	0.00372	0.0208	CbGeAlD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000479	0.00397	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—WNT1—breast cancer	0.000474	0.00393	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PTGER1—breast cancer	0.000451	0.00373	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—PDE2A—breast cancer	0.000442	0.00367	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—CCL27—breast cancer	0.000442	0.00367	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—CXCL3—breast cancer	0.000442	0.00367	CbGpPWpGaD
Vigabatrin—GABBR1—Neuronal System—COMT—breast cancer	0.00044	0.00365	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—AGTR2—breast cancer	0.000434	0.00359	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CXCL2—breast cancer	0.000434	0.00359	CbGpPWpGaD
Vigabatrin—ABAT—Transmission across Chemical Synapses—BRAF—breast cancer	0.000431	0.00357	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—PTHLH—breast cancer	0.000429	0.00355	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—EDNRB—breast cancer	0.000415	0.00344	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—WNT10B—breast cancer	0.000412	0.00342	CbGpPWpGaD
Vigabatrin—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—breast cancer	0.000408	0.00339	CbGpPWpGaD
Vigabatrin—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—breast cancer	0.000407	0.00337	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CCL27—breast cancer	0.000402	0.00333	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PDE2A—breast cancer	0.000402	0.00333	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CXCL3—breast cancer	0.000402	0.00333	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000398	0.0033	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—ABCG2—breast cancer	0.00039	0.00324	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CALCA—breast cancer	0.000377	0.00313	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CXCL12—breast cancer	0.000369	0.00306	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CXCR4—breast cancer	0.000369	0.00306	CbGpPWpGaD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—BRAF—breast cancer	0.000366	0.00304	CbGpPWpGaD
Vigabatrin—ABAT—Transmission across Chemical Synapses—MDM2—breast cancer	0.000361	0.00299	CbGpPWpGaD
Vigabatrin—ABAT—Transmission across Chemical Synapses—RAF1—breast cancer	0.00036	0.00298	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—TFRC—breast cancer	0.000348	0.00288	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—NCOA2—breast cancer	0.000335	0.00278	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—AGTR1—breast cancer	0.000333	0.00276	CbGpPWpGaD
Vigabatrin—ABAT—Neuronal System—BRAF—breast cancer	0.00033	0.00274	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—RGS2—breast cancer	0.000323	0.00268	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—CCL20—breast cancer	0.00032	0.00265	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.000319	0.00265	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CCDC88C—breast cancer	0.000313	0.00259	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—LGR6—breast cancer	0.000313	0.00259	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—LPAR1—breast cancer	0.00031	0.00257	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—SLC2A1—breast cancer	0.000309	0.00256	CbGpPWpGaD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—MDM2—breast cancer	0.000307	0.00255	CbGpPWpGaD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—RAF1—breast cancer	0.000306	0.00254	CbGpPWpGaD
Vigabatrin—SLC36A1—SLC-mediated transmembrane transport—ALB—breast cancer	0.0003	0.00249	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—GPER1—breast cancer	0.000299	0.00248	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—SFRP1—breast cancer	0.000299	0.00248	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—RGS2—breast cancer	0.000294	0.00243	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—PDE4D—breast cancer	0.000292	0.00242	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CCL20—breast cancer	0.00029	0.00241	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—NMBR—breast cancer	0.000286	0.00237	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—CNR2—breast cancer	0.000285	0.00236	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—NCOA1—breast cancer	0.000282	0.00234	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—LPAR1—breast cancer	0.000281	0.00233	CbGpPWpGaD
Vigabatrin—GABBR1—Neuronal System—BRAF—breast cancer	0.000281	0.00233	CbGpPWpGaD
Vigabatrin—ABAT—Neuronal System—MDM2—breast cancer	0.000277	0.00229	CbGpPWpGaD
Vigabatrin—ABAT—Neuronal System—RAF1—breast cancer	0.000276	0.00229	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—PLG—breast cancer	0.000275	0.00228	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CUL5—breast cancer	0.000266	0.00221	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PTGER1—breast cancer	0.000266	0.00221	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—HEYL—breast cancer	0.000266	0.00221	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PDE4D—breast cancer	0.000266	0.0022	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CNR2—breast cancer	0.000259	0.00214	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—HMOX1—breast cancer	0.000254	0.0021	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—CXCL8—breast cancer	0.000252	0.00209	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—RSPO3—breast cancer	0.00025	0.00207	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—CXCL2—breast cancer	0.000245	0.00203	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—AGTR2—breast cancer	0.000245	0.00203	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—ABCB1—breast cancer	0.000244	0.00202	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—WWOX—breast cancer	0.000243	0.00202	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—WNT10B—breast cancer	0.000243	0.00202	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—WNT1—breast cancer	0.000243	0.00202	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—PTHLH—breast cancer	0.000242	0.00201	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CCL27—breast cancer	0.000237	0.00197	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CXCL3—breast cancer	0.000237	0.00197	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—INHBB—breast cancer	0.000237	0.00197	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PDE2A—breast cancer	0.000237	0.00197	CbGpPWpGaD
Vigabatrin—GABBR1—Neuronal System—MDM2—breast cancer	0.000235	0.00195	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—EDNRB—breast cancer	0.000235	0.00195	CbGpPWpGaD
Vigabatrin—GABBR1—Neuronal System—RAF1—breast cancer	0.000234	0.00194	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—DLL4—breast cancer	0.000226	0.00188	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—BMPR2—breast cancer	0.000226	0.00188	CbGpPWpGaD
Vigabatrin—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—breast cancer	0.000224	0.00186	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CXCL2—breast cancer	0.000223	0.00184	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—AGTR2—breast cancer	0.000223	0.00184	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PTHLH—breast cancer	0.00022	0.00182	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CDH5—breast cancer	0.000217	0.0018	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—CALCA—breast cancer	0.000213	0.00177	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—EDNRB—breast cancer	0.000213	0.00177	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—SFRP2—breast cancer	0.000213	0.00176	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PRLR—breast cancer	0.000209	0.00173	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—CXCR4—breast cancer	0.000208	0.00173	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—CXCL12—breast cancer	0.000208	0.00173	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—GLI2—breast cancer	0.000202	0.00167	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—VCP—breast cancer	0.000202	0.00167	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—LEPR—breast cancer	0.000198	0.00164	CbGpPWpGaD
Vigabatrin—ABAT—Transmission across Chemical Synapses—HRAS—breast cancer	0.000198	0.00164	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CALCA—breast cancer	0.000194	0.00161	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CXCL12—breast cancer	0.000189	0.00157	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CXCR4—breast cancer	0.000189	0.00157	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—AGTR1—breast cancer	0.000188	0.00156	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—ARHGDIA—breast cancer	0.000184	0.00153	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—FST—breast cancer	0.00018	0.00149	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—HEY2—breast cancer	0.000178	0.00147	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—RPS6KB2—breast cancer	0.000175	0.00145	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—RGS2—breast cancer	0.000173	0.00144	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CCL20—breast cancer	0.000172	0.00142	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—AGTR1—breast cancer	0.000171	0.00142	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—ITPR1—breast cancer	0.000169	0.0014	CbGpPWpGaD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—HRAS—breast cancer	0.000168	0.0014	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—LPAR1—breast cancer	0.000166	0.00138	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—TLE3—breast cancer	0.000166	0.00138	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—HEY1—breast cancer	0.000164	0.00136	CbGpPWpGaD
Vigabatrin—Neuropathy peripheral—Doxorubicin—breast cancer	0.000163	0.000235	CcSEcCtD
Vigabatrin—Dizziness—Irinotecan—breast cancer	0.000162	0.000234	CcSEcCtD
Vigabatrin—Urinary tract infection—Doxorubicin—breast cancer	0.000162	0.000233	CcSEcCtD
Vigabatrin—Conjunctivitis—Doxorubicin—breast cancer	0.000162	0.000233	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—DLL1—breast cancer	0.000161	0.00134	CbGpPWpGaD
Vigabatrin—Nervous system disorder—Capecitabine—breast cancer	0.000161	0.000232	CcSEcCtD
Vigabatrin—Eye disorder—Methotrexate—breast cancer	0.000161	0.000232	CcSEcCtD
Vigabatrin—Diarrhoea—Fluorouracil—breast cancer	0.000161	0.000232	CcSEcCtD
Vigabatrin—Tinnitus—Methotrexate—breast cancer	0.000161	0.000232	CcSEcCtD
Vigabatrin—Hypoaesthesia—Epirubicin—breast cancer	0.00016	0.000231	CcSEcCtD
Vigabatrin—Skin disorder—Capecitabine—breast cancer	0.00016	0.00023	CcSEcCtD
Vigabatrin—Urticaria—Paclitaxel—breast cancer	0.000159	0.000229	CcSEcCtD
Vigabatrin—Oedema peripheral—Epirubicin—breast cancer	0.000159	0.000229	CcSEcCtD
Vigabatrin—Connective tissue disorder—Epirubicin—breast cancer	0.000158	0.000228	CcSEcCtD
Vigabatrin—Abdominal pain—Paclitaxel—breast cancer	0.000158	0.000228	CcSEcCtD
Vigabatrin—Body temperature increased—Paclitaxel—breast cancer	0.000158	0.000228	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—HIST1H2BK—breast cancer	0.000158	0.00131	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—HIST1H2BC—breast cancer	0.000158	0.00131	CbGpPWpGaD
Vigabatrin—Hepatobiliary disease—Doxorubicin—breast cancer	0.000157	0.000227	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—GRB7—breast cancer	0.000157	0.0013	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PDE4D—breast cancer	0.000157	0.0013	CbGpPWpGaD
Vigabatrin—Vomiting—Irinotecan—breast cancer	0.000156	0.000225	CcSEcCtD
Vigabatrin—Vomiting—Mitoxantrone—breast cancer	0.000156	0.000225	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—CSF2—breast cancer	0.000156	0.00129	CbGpPWpGaD
Vigabatrin—Sinusitis—Doxorubicin—breast cancer	0.000156	0.000225	CcSEcCtD
Vigabatrin—Dizziness—Fluorouracil—breast cancer	0.000156	0.000224	CcSEcCtD
Vigabatrin—Visual impairment—Epirubicin—breast cancer	0.000155	0.000224	CcSEcCtD
Vigabatrin—Rash—Mitoxantrone—breast cancer	0.000155	0.000223	CcSEcCtD
Vigabatrin—Rash—Irinotecan—breast cancer	0.000155	0.000223	CcSEcCtD
Vigabatrin—Dermatitis—Irinotecan—breast cancer	0.000155	0.000223	CcSEcCtD
Vigabatrin—Dermatitis—Mitoxantrone—breast cancer	0.000155	0.000223	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Docetaxel—breast cancer	0.000155	0.000223	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—TAB2—breast cancer	0.000154	0.00128	CbGpPWpGaD
Vigabatrin—Headache—Irinotecan—breast cancer	0.000154	0.000222	CcSEcCtD
Vigabatrin—Headache—Mitoxantrone—breast cancer	0.000154	0.000222	CcSEcCtD
Vigabatrin—Insomnia—Docetaxel—breast cancer	0.000154	0.000221	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—ITPR1—breast cancer	0.000154	0.00127	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CNR2—breast cancer	0.000153	0.00127	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CXCL8—breast cancer	0.000153	0.00127	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—MMP3—breast cancer	0.000153	0.00126	CbGpPWpGaD
Vigabatrin—Paraesthesia—Docetaxel—breast cancer	0.000152	0.00022	CcSEcCtD
Vigabatrin—Erythema multiforme—Epirubicin—breast cancer	0.000152	0.00022	CcSEcCtD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—ALB—breast cancer	0.000152	0.00126	CbGpPWpGaD
Vigabatrin—Vomiting—Gemcitabine—breast cancer	0.000152	0.000219	CcSEcCtD
Vigabatrin—ABAT—Neuronal System—HRAS—breast cancer	0.000152	0.00126	CbGpPWpGaD
Vigabatrin—Somnolence—Docetaxel—breast cancer	0.000151	0.000218	CcSEcCtD
Vigabatrin—Mental disorder—Methotrexate—breast cancer	0.000151	0.000218	CcSEcCtD
Vigabatrin—Rash—Gemcitabine—breast cancer	0.000151	0.000217	CcSEcCtD
Vigabatrin—Dermatitis—Gemcitabine—breast cancer	0.000151	0.000217	CcSEcCtD
Vigabatrin—Eye disorder—Epirubicin—breast cancer	0.000151	0.000217	CcSEcCtD
Vigabatrin—Tinnitus—Epirubicin—breast cancer	0.00015	0.000217	CcSEcCtD
Vigabatrin—Malnutrition—Methotrexate—breast cancer	0.00015	0.000216	CcSEcCtD
Vigabatrin—Headache—Gemcitabine—breast cancer	0.00015	0.000216	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Capecitabine—breast cancer	0.00015	0.000216	CcSEcCtD
Vigabatrin—Vomiting—Fluorouracil—breast cancer	0.00015	0.000216	CcSEcCtD
Vigabatrin—Dyspepsia—Docetaxel—breast cancer	0.000149	0.000215	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—DKK1—breast cancer	0.000149	0.00124	CbGpPWpGaD
Vigabatrin—Insomnia—Capecitabine—breast cancer	0.000149	0.000214	CcSEcCtD
Vigabatrin—Hypoaesthesia—Doxorubicin—breast cancer	0.000148	0.000214	CcSEcCtD
Vigabatrin—Rash—Fluorouracil—breast cancer	0.000148	0.000214	CcSEcCtD
Vigabatrin—Dermatitis—Fluorouracil—breast cancer	0.000148	0.000214	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—VEGFC—breast cancer	0.000148	0.00123	CbGpPWpGaD
Vigabatrin—Paraesthesia—Capecitabine—breast cancer	0.000148	0.000213	CcSEcCtD
Vigabatrin—Decreased appetite—Docetaxel—breast cancer	0.000148	0.000213	CcSEcCtD
Vigabatrin—Hypersensitivity—Paclitaxel—breast cancer	0.000148	0.000213	CcSEcCtD
Vigabatrin—Headache—Fluorouracil—breast cancer	0.000147	0.000212	CcSEcCtD
Vigabatrin—Oedema peripheral—Doxorubicin—breast cancer	0.000147	0.000212	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Docetaxel—breast cancer	0.000147	0.000211	CcSEcCtD
Vigabatrin—Connective tissue disorder—Doxorubicin—breast cancer	0.000147	0.000211	CcSEcCtD
Vigabatrin—Fatigue—Docetaxel—breast cancer	0.000146	0.000211	CcSEcCtD
Vigabatrin—Nausea—Irinotecan—breast cancer	0.000146	0.00021	CcSEcCtD
Vigabatrin—Nausea—Mitoxantrone—breast cancer	0.000146	0.00021	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—JAG2—breast cancer	0.000146	0.00121	CbGpPWpGaD
Vigabatrin—Pain—Docetaxel—breast cancer	0.000145	0.000209	CcSEcCtD
Vigabatrin—Constipation—Docetaxel—breast cancer	0.000145	0.000209	CcSEcCtD
Vigabatrin—Back pain—Methotrexate—breast cancer	0.000145	0.000209	CcSEcCtD
Vigabatrin—Dyspepsia—Capecitabine—breast cancer	0.000145	0.000209	CcSEcCtD
Vigabatrin—Visual impairment—Doxorubicin—breast cancer	0.000144	0.000207	CcSEcCtD
Vigabatrin—Asthenia—Paclitaxel—breast cancer	0.000144	0.000207	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—WNT1—breast cancer	0.000144	0.00119	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PLA2G4A—breast cancer	0.000143	0.00119	CbGpPWpGaD
Vigabatrin—Decreased appetite—Capecitabine—breast cancer	0.000143	0.000206	CcSEcCtD
Vigabatrin—Nausea—Gemcitabine—breast cancer	0.000142	0.000205	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Capecitabine—breast cancer	0.000142	0.000205	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—CSF2—breast cancer	0.000142	0.00118	CbGpPWpGaD
Vigabatrin—Fatigue—Capecitabine—breast cancer	0.000142	0.000204	CcSEcCtD
Vigabatrin—Pruritus—Paclitaxel—breast cancer	0.000142	0.000204	CcSEcCtD
Vigabatrin—Vision blurred—Methotrexate—breast cancer	0.000141	0.000204	CcSEcCtD
Vigabatrin—Mental disorder—Epirubicin—breast cancer	0.000141	0.000204	CcSEcCtD
Vigabatrin—Erythema multiforme—Doxorubicin—breast cancer	0.000141	0.000203	CcSEcCtD
Vigabatrin—Pain—Capecitabine—breast cancer	0.000141	0.000203	CcSEcCtD
Vigabatrin—Constipation—Capecitabine—breast cancer	0.000141	0.000203	CcSEcCtD
Vigabatrin—Malnutrition—Epirubicin—breast cancer	0.00014	0.000202	CcSEcCtD
Vigabatrin—Feeling abnormal—Docetaxel—breast cancer	0.00014	0.000202	CcSEcCtD
Vigabatrin—Nausea—Fluorouracil—breast cancer	0.00014	0.000201	CcSEcCtD
Vigabatrin—Eye disorder—Doxorubicin—breast cancer	0.000139	0.000201	CcSEcCtD
Vigabatrin—Ill-defined disorder—Methotrexate—breast cancer	0.000139	0.000201	CcSEcCtD
Vigabatrin—Tinnitus—Doxorubicin—breast cancer	0.000139	0.0002	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Docetaxel—breast cancer	0.000139	0.0002	CcSEcCtD
Vigabatrin—Anaemia—Methotrexate—breast cancer	0.000139	0.0002	CcSEcCtD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—RAF1—breast cancer	0.000138	0.00114	CbGpPWpGaD
Vigabatrin—Tension—Epirubicin—breast cancer	0.000138	0.000198	CcSEcCtD
Vigabatrin—Diarrhoea—Paclitaxel—breast cancer	0.000137	0.000198	CcSEcCtD
Vigabatrin—Nervousness—Epirubicin—breast cancer	0.000136	0.000196	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—NOTCH4—breast cancer	0.000136	0.00113	CbGpPWpGaD
Vigabatrin—Back pain—Epirubicin—breast cancer	0.000136	0.000196	CcSEcCtD
Vigabatrin—Feeling abnormal—Capecitabine—breast cancer	0.000135	0.000195	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—GZMB—breast cancer	0.000135	0.00112	CbGpPWpGaD
Vigabatrin—Malaise—Methotrexate—breast cancer	0.000135	0.000195	CcSEcCtD
Vigabatrin—Muscle spasms—Epirubicin—breast cancer	0.000135	0.000194	CcSEcCtD
Vigabatrin—Vertigo—Methotrexate—breast cancer	0.000135	0.000194	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Capecitabine—breast cancer	0.000134	0.000194	CcSEcCtD
Vigabatrin—Body temperature increased—Docetaxel—breast cancer	0.000134	0.000193	CcSEcCtD
Vigabatrin—Abdominal pain—Docetaxel—breast cancer	0.000134	0.000193	CcSEcCtD
Vigabatrin—Dizziness—Paclitaxel—breast cancer	0.000132	0.000191	CcSEcCtD
Vigabatrin—Vision blurred—Epirubicin—breast cancer	0.000132	0.000191	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—AGTR2—breast cancer	0.000131	0.00109	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CXCL2—breast cancer	0.000131	0.00109	CbGpPWpGaD
Vigabatrin—Cough—Methotrexate—breast cancer	0.000131	0.000189	CcSEcCtD
Vigabatrin—Mental disorder—Doxorubicin—breast cancer	0.000131	0.000188	CcSEcCtD
Vigabatrin—Urticaria—Capecitabine—breast cancer	0.000131	0.000188	CcSEcCtD
Vigabatrin—Ill-defined disorder—Epirubicin—breast cancer	0.00013	0.000188	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—PTHLH—breast cancer	0.00013	0.00108	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—BMP2—breast cancer	0.00013	0.00108	CbGpPWpGaD
Vigabatrin—Abdominal pain—Capecitabine—breast cancer	0.00013	0.000187	CcSEcCtD
Vigabatrin—Body temperature increased—Capecitabine—breast cancer	0.00013	0.000187	CcSEcCtD
Vigabatrin—Convulsion—Methotrexate—breast cancer	0.00013	0.000187	CcSEcCtD
Vigabatrin—Malnutrition—Doxorubicin—breast cancer	0.00013	0.000187	CcSEcCtD
Vigabatrin—Anaemia—Epirubicin—breast cancer	0.00013	0.000187	CcSEcCtD
Vigabatrin—GABBR1—Neuronal System—HRAS—breast cancer	0.000129	0.00107	CbGpPWpGaD
Vigabatrin—Agitation—Epirubicin—breast cancer	0.000129	0.000186	CcSEcCtD
Vigabatrin—Arthralgia—Methotrexate—breast cancer	0.000128	0.000184	CcSEcCtD
Vigabatrin—Chest pain—Methotrexate—breast cancer	0.000128	0.000184	CcSEcCtD
Vigabatrin—Myalgia—Methotrexate—breast cancer	0.000128	0.000184	CcSEcCtD
Vigabatrin—Tension—Doxorubicin—breast cancer	0.000127	0.000184	CcSEcCtD
Vigabatrin—Vomiting—Paclitaxel—breast cancer	0.000127	0.000184	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	0.000127	0.000183	CcSEcCtD
Vigabatrin—Malaise—Epirubicin—breast cancer	0.000127	0.000182	CcSEcCtD
Vigabatrin—Rash—Paclitaxel—breast cancer	0.000126	0.000182	CcSEcCtD
Vigabatrin—Dermatitis—Paclitaxel—breast cancer	0.000126	0.000182	CcSEcCtD
Vigabatrin—Discomfort—Methotrexate—breast cancer	0.000126	0.000182	CcSEcCtD
Vigabatrin—Nervousness—Doxorubicin—breast cancer	0.000126	0.000182	CcSEcCtD
Vigabatrin—Vertigo—Epirubicin—breast cancer	0.000126	0.000182	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—EDNRB—breast cancer	0.000126	0.00104	CbGpPWpGaD
Vigabatrin—Back pain—Doxorubicin—breast cancer	0.000126	0.000181	CcSEcCtD
Vigabatrin—Headache—Paclitaxel—breast cancer	0.000126	0.000181	CcSEcCtD
Vigabatrin—Hypersensitivity—Docetaxel—breast cancer	0.000125	0.00018	CcSEcCtD
Vigabatrin—Muscle spasms—Doxorubicin—breast cancer	0.000125	0.00018	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—PGR—breast cancer	0.000125	0.00103	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—THBS1—breast cancer	0.000124	0.00103	CbGpPWpGaD
Vigabatrin—Confusional state—Methotrexate—breast cancer	0.000123	0.000178	CcSEcCtD
Vigabatrin—Cough—Epirubicin—breast cancer	0.000122	0.000177	CcSEcCtD
Vigabatrin—Vision blurred—Doxorubicin—breast cancer	0.000122	0.000176	CcSEcCtD
Vigabatrin—Asthenia—Docetaxel—breast cancer	0.000122	0.000176	CcSEcCtD
Vigabatrin—Convulsion—Epirubicin—breast cancer	0.000122	0.000175	CcSEcCtD
Vigabatrin—Infection—Methotrexate—breast cancer	0.000122	0.000175	CcSEcCtD
Vigabatrin—Hypersensitivity—Capecitabine—breast cancer	0.000121	0.000175	CcSEcCtD
Vigabatrin—Ill-defined disorder—Doxorubicin—breast cancer	0.00012	0.000174	CcSEcCtD
Vigabatrin—Pruritus—Docetaxel—breast cancer	0.00012	0.000173	CcSEcCtD
Vigabatrin—Nervous system disorder—Methotrexate—breast cancer	0.00012	0.000173	CcSEcCtD
Vigabatrin—Anaemia—Doxorubicin—breast cancer	0.00012	0.000173	CcSEcCtD
Vigabatrin—Arthralgia—Epirubicin—breast cancer	0.000119	0.000172	CcSEcCtD
Vigabatrin—Chest pain—Epirubicin—breast cancer	0.000119	0.000172	CcSEcCtD
Vigabatrin—Myalgia—Epirubicin—breast cancer	0.000119	0.000172	CcSEcCtD
Vigabatrin—Agitation—Doxorubicin—breast cancer	0.000119	0.000172	CcSEcCtD
Vigabatrin—Anxiety—Epirubicin—breast cancer	0.000119	0.000172	CcSEcCtD
Vigabatrin—Nausea—Paclitaxel—breast cancer	0.000119	0.000172	CcSEcCtD
Vigabatrin—Skin disorder—Methotrexate—breast cancer	0.000119	0.000171	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	0.000119	0.000171	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—FLT1—breast cancer	0.000118	0.000981	CbGpPWpGaD
Vigabatrin—Discomfort—Epirubicin—breast cancer	0.000118	0.00017	CcSEcCtD
Vigabatrin—Asthenia—Capecitabine—breast cancer	0.000118	0.00017	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—SQSTM1—breast cancer	0.000118	0.000977	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—FGF3—breast cancer	0.000118	0.000977	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—PIK3CG—breast cancer	0.000117	0.000972	CbGpPWpGaD
Vigabatrin—Malaise—Doxorubicin—breast cancer	0.000117	0.000169	CcSEcCtD
Vigabatrin—Vertigo—Doxorubicin—breast cancer	0.000117	0.000168	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—JAG1—breast cancer	0.000116	0.000964	CbGpPWpGaD
Vigabatrin—Pruritus—Capecitabine—breast cancer	0.000116	0.000168	CcSEcCtD
Vigabatrin—Diarrhoea—Docetaxel—breast cancer	0.000116	0.000167	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—PARP1—breast cancer	0.000116	0.00096	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—NOTCH3—breast cancer	0.000116	0.00096	CbGpPWpGaD
Vigabatrin—Confusional state—Epirubicin—breast cancer	0.000115	0.000166	CcSEcCtD
Vigabatrin—Oedema—Epirubicin—breast cancer	0.000115	0.000165	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—CALCA—breast cancer	0.000114	0.000949	CbGpPWpGaD
Vigabatrin—Infection—Epirubicin—breast cancer	0.000114	0.000164	CcSEcCtD
Vigabatrin—Cough—Doxorubicin—breast cancer	0.000113	0.000163	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—RPS6—breast cancer	0.000113	0.000937	CbGpPWpGaD
Vigabatrin—Convulsion—Doxorubicin—breast cancer	0.000113	0.000162	CcSEcCtD
Vigabatrin—Diarrhoea—Capecitabine—breast cancer	0.000112	0.000162	CcSEcCtD
Vigabatrin—Nervous system disorder—Epirubicin—breast cancer	0.000112	0.000162	CcSEcCtD
Vigabatrin—Dizziness—Docetaxel—breast cancer	0.000112	0.000162	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—FGF4—breast cancer	0.000112	0.00093	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CXCR4—breast cancer	0.000112	0.000926	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CXCL12—breast cancer	0.000112	0.000926	CbGpPWpGaD
Vigabatrin—Musculoskeletal discomfort—Methotrexate—breast cancer	0.000112	0.000161	CcSEcCtD
Vigabatrin—Skin disorder—Epirubicin—breast cancer	0.000111	0.00016	CcSEcCtD
Vigabatrin—Insomnia—Methotrexate—breast cancer	0.000111	0.00016	CcSEcCtD
Vigabatrin—Chest pain—Doxorubicin—breast cancer	0.000111	0.000159	CcSEcCtD
Vigabatrin—Myalgia—Doxorubicin—breast cancer	0.000111	0.000159	CcSEcCtD
Vigabatrin—Arthralgia—Doxorubicin—breast cancer	0.000111	0.000159	CcSEcCtD
Vigabatrin—Anxiety—Doxorubicin—breast cancer	0.00011	0.000159	CcSEcCtD
Vigabatrin—Paraesthesia—Methotrexate—breast cancer	0.00011	0.000158	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	0.00011	0.000158	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—PAK1—breast cancer	0.00011	0.000909	CbGpPWpGaD
Vigabatrin—Discomfort—Doxorubicin—breast cancer	0.000109	0.000157	CcSEcCtD
Vigabatrin—Somnolence—Methotrexate—breast cancer	0.000109	0.000157	CcSEcCtD
Vigabatrin—Dizziness—Capecitabine—breast cancer	0.000109	0.000157	CcSEcCtD
Vigabatrin—Vomiting—Docetaxel—breast cancer	0.000108	0.000156	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—TCF7L2—breast cancer	0.000108	0.000893	CbGpPWpGaD
Vigabatrin—Dyspepsia—Methotrexate—breast cancer	0.000108	0.000155	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—AKT2—breast cancer	0.000107	0.000889	CbGpPWpGaD
Vigabatrin—Rash—Docetaxel—breast cancer	0.000107	0.000154	CcSEcCtD
Vigabatrin—Dermatitis—Docetaxel—breast cancer	0.000107	0.000154	CcSEcCtD
Vigabatrin—Confusional state—Doxorubicin—breast cancer	0.000107	0.000154	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—PIK3CG—breast cancer	0.000106	0.000883	CbGpPWpGaD
Vigabatrin—Decreased appetite—Methotrexate—breast cancer	0.000106	0.000153	CcSEcCtD
Vigabatrin—Headache—Docetaxel—breast cancer	0.000106	0.000153	CcSEcCtD
Vigabatrin—Oedema—Doxorubicin—breast cancer	0.000106	0.000153	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Methotrexate—breast cancer	0.000106	0.000152	CcSEcCtD
Vigabatrin—Fatigue—Methotrexate—breast cancer	0.000106	0.000152	CcSEcCtD
Vigabatrin—Infection—Doxorubicin—breast cancer	0.000105	0.000152	CcSEcCtD
Vigabatrin—Pain—Methotrexate—breast cancer	0.000105	0.000151	CcSEcCtD
Vigabatrin—Vomiting—Capecitabine—breast cancer	0.000105	0.000151	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Epirubicin—breast cancer	0.000104	0.00015	CcSEcCtD
Vigabatrin—Nervous system disorder—Doxorubicin—breast cancer	0.000104	0.00015	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—NOTCH2—breast cancer	0.000104	0.000861	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—HSP90AA1—breast cancer	0.000104	0.000861	CbGpPWpGaD
Vigabatrin—Rash—Capecitabine—breast cancer	0.000104	0.000149	CcSEcCtD
Vigabatrin—Insomnia—Epirubicin—breast cancer	0.000104	0.000149	CcSEcCtD
Vigabatrin—Dermatitis—Capecitabine—breast cancer	0.000104	0.000149	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—PIK3CD—breast cancer	0.000103	0.000854	CbGpPWpGaD
Vigabatrin—Headache—Capecitabine—breast cancer	0.000103	0.000148	CcSEcCtD
Vigabatrin—Skin disorder—Doxorubicin—breast cancer	0.000103	0.000148	CcSEcCtD
Vigabatrin—Paraesthesia—Epirubicin—breast cancer	0.000103	0.000148	CcSEcCtD
Vigabatrin—Somnolence—Epirubicin—breast cancer	0.000102	0.000147	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—PRL—breast cancer	0.000101	0.000838	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—AGTR1—breast cancer	0.000101	0.000838	CbGpPWpGaD
Vigabatrin—Nausea—Docetaxel—breast cancer	0.000101	0.000145	CcSEcCtD
Vigabatrin—Feeling abnormal—Methotrexate—breast cancer	0.000101	0.000145	CcSEcCtD
Vigabatrin—Dyspepsia—Epirubicin—breast cancer	0.000101	0.000145	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Methotrexate—breast cancer	0.0001	0.000144	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—STK11—breast cancer	9.96e-05	0.000826	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—ADAM10—breast cancer	9.96e-05	0.000826	CbGpPWpGaD
Vigabatrin—Decreased appetite—Epirubicin—breast cancer	9.96e-05	0.000144	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Epirubicin—breast cancer	9.89e-05	0.000143	CcSEcCtD
Vigabatrin—Fatigue—Epirubicin—breast cancer	9.88e-05	0.000142	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—PLG—breast cancer	9.85e-05	0.000817	CbGpPWpGaD
Vigabatrin—Constipation—Epirubicin—breast cancer	9.8e-05	0.000141	CcSEcCtD
Vigabatrin—Pain—Epirubicin—breast cancer	9.8e-05	0.000141	CcSEcCtD
Vigabatrin—Nausea—Capecitabine—breast cancer	9.77e-05	0.000141	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—AKT2—breast cancer	9.74e-05	0.000808	CbGpPWpGaD
Vigabatrin—Urticaria—Methotrexate—breast cancer	9.72e-05	0.00014	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—FGF10—breast cancer	9.69e-05	0.000803	CbGpPWpGaD
Vigabatrin—Body temperature increased—Methotrexate—breast cancer	9.68e-05	0.000139	CcSEcCtD
Vigabatrin—Abdominal pain—Methotrexate—breast cancer	9.68e-05	0.000139	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Doxorubicin—breast cancer	9.66e-05	0.000139	CcSEcCtD
Vigabatrin—Insomnia—Doxorubicin—breast cancer	9.59e-05	0.000138	CcSEcCtD
Vigabatrin—Paraesthesia—Doxorubicin—breast cancer	9.52e-05	0.000137	CcSEcCtD
Vigabatrin—Feeling abnormal—Epirubicin—breast cancer	9.44e-05	0.000136	CcSEcCtD
Vigabatrin—Somnolence—Doxorubicin—breast cancer	9.42e-05	0.000136	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Epirubicin—breast cancer	9.37e-05	0.000135	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—PIK3CD—breast cancer	9.36e-05	0.000776	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PDGFA—breast cancer	9.35e-05	0.000775	CbGpPWpGaD
Vigabatrin—Dyspepsia—Doxorubicin—breast cancer	9.33e-05	0.000134	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—TGFBR2—breast cancer	9.22e-05	0.000764	CbGpPWpGaD
Vigabatrin—Decreased appetite—Doxorubicin—breast cancer	9.21e-05	0.000133	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Doxorubicin—breast cancer	9.15e-05	0.000132	CcSEcCtD
Vigabatrin—Fatigue—Doxorubicin—breast cancer	9.14e-05	0.000132	CcSEcCtD
Vigabatrin—Urticaria—Epirubicin—breast cancer	9.1e-05	0.000131	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—ITPR1—breast cancer	9.07e-05	0.000752	CbGpPWpGaD
Vigabatrin—Pain—Doxorubicin—breast cancer	9.06e-05	0.000131	CcSEcCtD
Vigabatrin—Constipation—Doxorubicin—breast cancer	9.06e-05	0.000131	CcSEcCtD
Vigabatrin—Body temperature increased—Epirubicin—breast cancer	9.05e-05	0.000131	CcSEcCtD
Vigabatrin—Abdominal pain—Epirubicin—breast cancer	9.05e-05	0.000131	CcSEcCtD
Vigabatrin—Hypersensitivity—Methotrexate—breast cancer	9.02e-05	0.00013	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—STAT5A—breast cancer	9.01e-05	0.000747	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MMP3—breast cancer	9.01e-05	0.000747	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—ERBB4—breast cancer	9.01e-05	0.000747	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—PIK3CB—breast cancer	8.98e-05	0.000745	CbGpPWpGaD
Vigabatrin—Asthenia—Methotrexate—breast cancer	8.78e-05	0.000127	CcSEcCtD
Vigabatrin—Feeling abnormal—Doxorubicin—breast cancer	8.73e-05	0.000126	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—SMAD4—breast cancer	8.73e-05	0.000723	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—IGF1R—breast cancer	8.67e-05	0.000719	CbGpPWpGaD
Vigabatrin—Gastrointestinal pain—Doxorubicin—breast cancer	8.67e-05	0.000125	CcSEcCtD
Vigabatrin—Pruritus—Methotrexate—breast cancer	8.66e-05	0.000125	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—CXCL8—breast cancer	8.63e-05	0.000716	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—HES1—breast cancer	8.52e-05	0.000706	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PLA2G4A—breast cancer	8.47e-05	0.000702	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—NCOR1—breast cancer	8.47e-05	0.000702	CbGpPWpGaD
Vigabatrin—Hypersensitivity—Epirubicin—breast cancer	8.44e-05	0.000122	CcSEcCtD
Vigabatrin—Urticaria—Doxorubicin—breast cancer	8.42e-05	0.000121	CcSEcCtD
Vigabatrin—Abdominal pain—Doxorubicin—breast cancer	8.38e-05	0.000121	CcSEcCtD
Vigabatrin—Body temperature increased—Doxorubicin—breast cancer	8.38e-05	0.000121	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—FGF1—breast cancer	8.38e-05	0.000694	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CSF2—breast cancer	8.38e-05	0.000694	CbGpPWpGaD
Vigabatrin—Diarrhoea—Methotrexate—breast cancer	8.37e-05	0.000121	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—RAF1—breast cancer	8.36e-05	0.000693	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—NRG1—breast cancer	8.31e-05	0.000689	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—H2AFX—breast cancer	8.25e-05	0.000684	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—IL2—breast cancer	8.25e-05	0.000684	CbGpPWpGaD
Vigabatrin—Asthenia—Epirubicin—breast cancer	8.22e-05	0.000118	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—E2F1—breast cancer	8.2e-05	0.000679	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PIK3CB—breast cancer	8.16e-05	0.000676	CbGpPWpGaD
Vigabatrin—Pruritus—Epirubicin—breast cancer	8.1e-05	0.000117	CcSEcCtD
Vigabatrin—Dizziness—Methotrexate—breast cancer	8.09e-05	0.000117	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—SPP1—breast cancer	7.87e-05	0.000653	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CXCL8—breast cancer	7.84e-05	0.00065	CbGpPWpGaD
Vigabatrin—Diarrhoea—Epirubicin—breast cancer	7.84e-05	0.000113	CcSEcCtD
Vigabatrin—Hypersensitivity—Doxorubicin—breast cancer	7.81e-05	0.000113	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—ERBB3—breast cancer	7.79e-05	0.000646	CbGpPWpGaD
Vigabatrin—Vomiting—Methotrexate—breast cancer	7.78e-05	0.000112	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—FGFR2—breast cancer	7.78e-05	0.000645	CbGpPWpGaD
Vigabatrin—Rash—Methotrexate—breast cancer	7.72e-05	0.000111	CcSEcCtD
Vigabatrin—Dermatitis—Methotrexate—breast cancer	7.71e-05	0.000111	CcSEcCtD
Vigabatrin—Headache—Methotrexate—breast cancer	7.67e-05	0.000111	CcSEcCtD
Vigabatrin—Asthenia—Doxorubicin—breast cancer	7.6e-05	0.00011	CcSEcCtD
Vigabatrin—Dizziness—Epirubicin—breast cancer	7.57e-05	0.000109	CcSEcCtD
Vigabatrin—Pruritus—Doxorubicin—breast cancer	7.5e-05	0.000108	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—IL2—breast cancer	7.49e-05	0.000621	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—TERT—breast cancer	7.47e-05	0.000619	CbGpPWpGaD
Vigabatrin—Vomiting—Epirubicin—breast cancer	7.28e-05	0.000105	CcSEcCtD
Vigabatrin—Nausea—Methotrexate—breast cancer	7.27e-05	0.000105	CcSEcCtD
Vigabatrin—Diarrhoea—Doxorubicin—breast cancer	7.25e-05	0.000105	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—FGFR1—breast cancer	7.25e-05	0.000601	CbGpPWpGaD
Vigabatrin—Rash—Epirubicin—breast cancer	7.22e-05	0.000104	CcSEcCtD
Vigabatrin—Dermatitis—Epirubicin—breast cancer	7.22e-05	0.000104	CcSEcCtD
Vigabatrin—Headache—Epirubicin—breast cancer	7.18e-05	0.000103	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—HIF1A—breast cancer	7.14e-05	0.000592	CbGpPWpGaD
Vigabatrin—Dizziness—Doxorubicin—breast cancer	7.01e-05	0.000101	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—LEP—breast cancer	6.97e-05	0.000578	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CAV1—breast cancer	6.91e-05	0.000572	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—KDR—breast cancer	6.83e-05	0.000566	CbGpPWpGaD
Vigabatrin—Nausea—Epirubicin—breast cancer	6.8e-05	9.81e-05	CcSEcCtD
Vigabatrin—Vomiting—Doxorubicin—breast cancer	6.74e-05	9.71e-05	CcSEcCtD
Vigabatrin—Rash—Doxorubicin—breast cancer	6.68e-05	9.63e-05	CcSEcCtD
Vigabatrin—Dermatitis—Doxorubicin—breast cancer	6.68e-05	9.62e-05	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—ESR1—breast cancer	6.65e-05	0.000552	CbGpPWpGaD
Vigabatrin—Headache—Doxorubicin—breast cancer	6.64e-05	9.57e-05	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—FN1—breast cancer	6.57e-05	0.000545	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—NFKBIA—breast cancer	6.49e-05	0.000538	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—NOTCH1—breast cancer	6.43e-05	0.000533	CbGpPWpGaD
Vigabatrin—Nausea—Doxorubicin—breast cancer	6.3e-05	9.07e-05	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—KIT—breast cancer	6.29e-05	0.000521	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PIK3CG—breast cancer	6.29e-05	0.000521	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—APC—breast cancer	6.29e-05	0.000521	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—EGF—breast cancer	6.22e-05	0.000515	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—MAPK3—breast cancer	6.02e-05	0.000499	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—BRAF—breast cancer	5.91e-05	0.00049	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—IGF1—breast cancer	5.76e-05	0.000477	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—AKT2—breast cancer	5.75e-05	0.000477	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—EGFR—breast cancer	5.73e-05	0.000475	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PIK3CD—breast cancer	5.53e-05	0.000458	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—PIK3CA—breast cancer	5.48e-05	0.000454	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—SERPINE1—breast cancer	5.47e-05	0.000453	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—KRAS—breast cancer	5.41e-05	0.000449	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—NOS3—breast cancer	5.22e-05	0.000433	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PIK3CA—breast cancer	4.97e-05	0.000412	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MDM2—breast cancer	4.95e-05	0.000411	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—RAF1—breast cancer	4.94e-05	0.000409	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—RELA—breast cancer	4.91e-05	0.000407	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—ERBB2—breast cancer	4.88e-05	0.000405	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MTOR—breast cancer	4.82e-05	0.000399	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PIK3CB—breast cancer	4.82e-05	0.000399	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CXCL8—breast cancer	4.63e-05	0.000384	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—HRAS—breast cancer	4.6e-05	0.000381	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CDKN1B—breast cancer	4.52e-05	0.000375	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—AKT1—breast cancer	4.47e-05	0.000371	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CASP3—breast cancer	4.43e-05	0.000367	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—IL2—breast cancer	4.43e-05	0.000367	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—IL6—breast cancer	4.4e-05	0.000365	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CCND1—breast cancer	4.31e-05	0.000358	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—JUN—breast cancer	4.31e-05	0.000357	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CTNNB1—breast cancer	4.27e-05	0.000354	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MMP9—breast cancer	4.19e-05	0.000347	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CDKN1A—breast cancer	4.17e-05	0.000346	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PTEN—breast cancer	4.16e-05	0.000345	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MAPK8—breast cancer	4.07e-05	0.000338	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—AKT1—breast cancer	4.06e-05	0.000337	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—SRC—breast cancer	3.86e-05	0.00032	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—VEGFA—breast cancer	3.76e-05	0.000312	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—STAT3—breast cancer	3.72e-05	0.000309	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MAPK3—breast cancer	3.56e-05	0.000295	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MYC—breast cancer	3.46e-05	0.000287	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—TGFB1—breast cancer	3.45e-05	0.000286	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—EGFR—breast cancer	3.39e-05	0.000281	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—KRAS—breast cancer	3.2e-05	0.000265	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PIK3CA—breast cancer	2.94e-05	0.000244	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—TP53—breast cancer	2.84e-05	0.000236	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—HRAS—breast cancer	2.72e-05	0.000225	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—IL6—breast cancer	2.6e-05	0.000216	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—AKT1—breast cancer	2.4e-05	0.000199	CbGpPWpGaD
